Evercore ISI Raises Privia Health Group (NASDAQ:PRVA) Price Target to $30.00

Privia Health Group (NASDAQ:PRVA) had its target price hoisted by analysts at Evercore ISI from $28.00 to $30.00 in a research report issued on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Evercore ISI’s price target indicates a potential upside of 27.01% from the company’s previous close.

Other research analysts have also recently issued research reports about the company. Citizens Jmp boosted their price objective on Privia Health Group from $30.00 to $31.00 and gave the stock a “market outperform” rating in a research report on Friday. Zacks Research raised Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 19th. Piper Sandler dropped their target price on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a research note on Monday, August 11th. Weiss Ratings restated a “sell (d+)” rating on shares of Privia Health Group in a research note on Wednesday, October 8th. Finally, Stephens restated an “overweight” rating and set a $32.00 price target on shares of Privia Health Group in a research note on Wednesday, September 24th. Twelve investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $29.25.

Privia Health Group Stock Performance

NASDAQ:PRVA traded down $0.36 on Friday, hitting $23.62. The stock had a trading volume of 431,479 shares, compared to its average volume of 843,592. The stock has a market cap of $2.90 billion, a P/E ratio of 214.33, a price-to-earnings-growth ratio of 3.41 and a beta of 0.83. Privia Health Group has a 1 year low of $18.77 and a 1 year high of $26.51. The firm’s fifty day simple moving average is $24.14 and its two-hundred day simple moving average is $22.76.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. The firm had revenue of $213.61 million for the quarter. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%. Equities research analysts predict that Privia Health Group will post 0.14 EPS for the current year.

Institutional Investors Weigh In On Privia Health Group

A number of institutional investors and hedge funds have recently bought and sold shares of PRVA. Teacher Retirement System of Texas bought a new stake in Privia Health Group during the first quarter valued at approximately $387,000. Cerity Partners LLC raised its position in shares of Privia Health Group by 122.1% during the 1st quarter. Cerity Partners LLC now owns 25,821 shares of the company’s stock valued at $580,000 after buying an additional 14,195 shares in the last quarter. Stephens Inc. AR purchased a new stake in shares of Privia Health Group during the 1st quarter valued at $300,000. CWM LLC lifted its holdings in shares of Privia Health Group by 50.3% during the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after acquiring an additional 604 shares during the last quarter. Finally, MQS Management LLC purchased a new position in Privia Health Group in the first quarter worth $210,000. 94.48% of the stock is owned by hedge funds and other institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.